+

WO1991015582A3 - Proto-oncogenes gap purifies, sequences de ces proto-oncogenes et utilisation - Google Patents

Proto-oncogenes gap purifies, sequences de ces proto-oncogenes et utilisation Download PDF

Info

Publication number
WO1991015582A3
WO1991015582A3 PCT/US1991/001763 US9101763W WO9115582A3 WO 1991015582 A3 WO1991015582 A3 WO 1991015582A3 US 9101763 W US9101763 W US 9101763W WO 9115582 A3 WO9115582 A3 WO 9115582A3
Authority
WO
WIPO (PCT)
Prior art keywords
rap
gaps
methods
proteins
purified
Prior art date
Application number
PCT/US1991/001763
Other languages
English (en)
Other versions
WO1991015582A2 (fr
Inventor
Paul G Polakis
Francis P Mccormick
Bonnee Rubinfield
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of WO1991015582A2 publication Critical patent/WO1991015582A2/fr
Publication of WO1991015582A3 publication Critical patent/WO1991015582A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention porte essentiellement sur des proto-oncogènes purifiés 'rap GAP' (protéines activantes triphosphatase guanine proche ras), sur des procédés de purification des protéines soit par étapes chromatographiques successives, soit par traitement à l'aide d'anticorps monoclonaux, soit par séquences amino-acides partielles de la protéine. L'invention porte également sur l'ADN et les séquences amino-acides prévues de tels proto-oncogènes et sur les procédés de production de ces anticoprs. L'invention porte enfin sur des procédés de définition de thérapie anti-cancer mettant en ÷uvre ces proto-oncogènes.
PCT/US1991/001763 1990-03-30 1991-03-15 Proto-oncogenes gap purifies, sequences de ces proto-oncogenes et utilisation WO1991015582A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50233290A 1990-03-30 1990-03-30
US502,332 1990-03-30
US64280191A 1991-01-18 1991-01-18
US642,801 1991-01-18

Publications (2)

Publication Number Publication Date
WO1991015582A2 WO1991015582A2 (fr) 1991-10-17
WO1991015582A3 true WO1991015582A3 (fr) 1991-12-12

Family

ID=27054118

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/001763 WO1991015582A2 (fr) 1990-03-30 1991-03-15 Proto-oncogenes gap purifies, sequences de ces proto-oncogenes et utilisation

Country Status (3)

Country Link
EP (1) EP0537155A1 (fr)
AU (1) AU7554691A (fr)
WO (1) WO1991015582A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830684A (en) * 1988-08-10 1998-11-03 Chiron Corporation Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer
CA2065634C (fr) * 1991-04-11 1997-06-03 Alec A. Piplani Greffon endovasculaire ayant une bifurcation et appareil et methode servant a le deployer
US6072154A (en) 1996-09-05 2000-06-06 Medtronic, Inc. Selectively activated shape memory device
US6238881B1 (en) 1996-11-06 2001-05-29 Onyx Pharmaceuticals, Inc. Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
CA2351361A1 (fr) * 1998-11-23 2000-06-02 Incyte Pharmaceuticals, Inc. Proteines associees a la gtpase
AU5309500A (en) * 1999-06-07 2000-12-28 Lexicon Genetics Incorporated Novel human genes and proteins encoded thereby

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000607A2 (fr) * 1988-07-08 1990-01-25 Cetus Corporation Sequences de genes de gap et utilisations diagnostiques de telles sequences

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000607A2 (fr) * 1988-07-08 1990-01-25 Cetus Corporation Sequences de genes de gap et utilisations diagnostiques de telles sequences

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Nature, vol. 335, 1 September 1988, U.S. Vogel et al.: "Cloning of bovine GAP and its interaction with oncogenic ras p21", pages 90-93, see the whole article *
Proc. Natl. Acad. Sci. USA, vol. 85, July 1988, Biochemistry, J.B. Gibbs et al.: "Purification of ras GTPase activating protein from bovine brain", pages 5026-30, see the whole document *
Proc. Natl. Acad. Sci. USA, vol. 88, January 1991, Biochemistry, P.G. Polakis et al.: "Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells", pages 239-243, see the whole document *
Science, vol. 242, 23 December 1988, M. Trahey et al.: "Molecular cloning of two types of GAP complementary DNA from human placenta", pages 1697-1700, see the whole article *
The Journal of Biological Chemistry, vol. 264, no. 16, 5 June 1989, The American Society for Biochemistry and Molecular Biology, Inc. (US), A. Kikuchi et al.: "Purification and characterization from bovine brain cytosol of two GTPase-activating proteins specific for smg p21, a GTP-binding protein having the same effector domain as c-ras p21s", pages 9133-9136, see the whole document (cited in the application) *

Also Published As

Publication number Publication date
WO1991015582A2 (fr) 1991-10-17
AU7554691A (en) 1991-10-30
EP0537155A1 (fr) 1993-04-21

Similar Documents

Publication Publication Date Title
MX9603637A (es) Purificacion de anticuerpo.
EP0186833B1 (fr) Anticorps monoclonal contre une cytotoxine, hybridome le produisant et procédé pour la préparation de la cytotoxine
WO2003059935A3 (fr) Methodes de purification d'une proteine
JP4001604B2 (ja) 新規蛋白質及びこれを使用した薬剤の製法
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
DE69434166D1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
NO913186D0 (no) Fremgangsmaate for anvendelse og syntese av peptider.
CA2220447A1 (fr) Nouveaux procedes de recuperation et de purification de proteines de fusion
WO1988009818A2 (fr) Recepteur d'hormone de croissance
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
KR950700779A (ko) 단백질의 정제방법(Protein purification)
WO1995006735A3 (fr) Sequences nucleotidiques servant a coder de nouvelles tyrosine-phosphatases proteiques
WO1991015582A3 (fr) Proto-oncogenes gap purifies, sequences de ces proto-oncogenes et utilisation
WO2000017356A3 (fr) Lynx, une nouvelle famille de ligands recepteurs dans le systeme nerveux central, acides nucleiques et proteines correspondants et leurs utilisations
JP2002542163A (ja) 血漿成分の分離
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
EP0239311A3 (fr) Séparation mutuelle de protéines
WO1996023884A3 (fr) Recepteurs humains actives par les proliferateurs du peroxisome
Deutsch Relationships of two light chain immunoglobulins isolated from the same human source (low molecular weight immunoglobins)
WO1996021020A3 (fr) Sequences virales de la maladie de borna et procedes diagnostiques et therapeutiques destines aux affections du systeme nerveux
DE69637941D1 (de) Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
Fountoulakis et al. A 25-kDa stretch of the extracellular domain of the human interferon gamma receptor is required for full ligand binding capacity
Hervé et al. Two-step chromatographic purification of human plasma α1-acid glycoprotein Its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent
CA2112701A1 (fr) Polypeptides des proteines s et leur utilisation
WO2000017363A3 (fr) MOLECULE DU TYPE INTERLEUKINE-1: INTERLEUKINE-1z, ACIDES NUCLEIQUES, POLYPEPTIDES, ANTICORPS ET LEURS APPLICATIONS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PAT.BUL.24/91,UNDER PUBLISHED REPLACE "A1" BY "A2"

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991907352

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991907352

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1991907352

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载